[Chronic kidney failure].
Shimojyo
Fumitake
F
D000686:Amyloidosis / Q000209:etiology / Q000628:therapy; D000740:Anemia / Q000188:drug therapy / Q000209:etiology; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D002216:Captopril / Q000627:therapeutic use; D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000188:drug therapy / Q000209:etiology; D003956:Dialysis / Q000009:adverse effects / Q000379:methods / Q000639:trends; D018753:Diet, Protein-Restricted; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy; D009145:Mushroom Poisoning / Q000150:complications; D020258:Neurotoxicity Syndromes / Q000209:etiology
D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D002216:Captopril